BioNeutra Global Corporation
BGACF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $1,230 | $220 | $6,459 | $6,162 |
| - Cash | $1,889 | $723 | $839 | $934 |
| + Debt | $7,641 | $7,005 | $6,893 | $7,075 |
| Enterprise Value | $6,982 | $6,503 | $12,513 | $12,303 |
| Revenue | $11,383 | $13,391 | $15,401 | $24,116 |
| % Growth | -15% | -13.1% | -36.1% | – |
| Gross Profit | $4,143 | $2,348 | $2,891 | $3,944 |
| % Margin | 36.4% | 17.5% | 18.8% | 16.4% |
| EBITDA | -$352 | -$1,360 | -$1,115 | -$1,498 |
| % Margin | -3.1% | -10.2% | -7.2% | -6.2% |
| Net Income | -$2,108 | -$2,921 | -$2,830 | -$3,707 |
| % Margin | -18.5% | -21.8% | -18.4% | -15.4% |
| EPS Diluted | -0.045 | -0.063 | -0.061 | -0.08 |
| % Growth | 27.8% | -3.3% | 23.7% | – |
| Operating Cash Flow | $683 | $838 | $271 | $1,433 |
| Capital Expenditures | -$19 | -$204 | -$277 | -$76 |
| Free Cash Flow | $664 | $635 | -$6 | $1,357 |